Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>MZL R/R*** > Treatment > CN. B. BTK Inhibitor Capsules>

---

CN. B. BTK Inhibitor Capsules>'s subsections
(*) BR Approval Date: 2022. 11.10
(*) CA Approval Date: 2022. 03.03.
(*) EU CE Mark Date: 2022. 11.02
(*) UK Approval Date: 2023. 01.19
(*) USA Approval Date: 2021. 09.15
>Received>1 Anti CD20-based Regimen
Company
Generic Name:
Patent>Assignee; Claims; No.; Etc
Patent>Total USA No.: 4
Patent>UpDate: 2021. 09.14
RTM
RTM Web-Site

CN. B. BTK Inhibitor Capsules>'s products
This section has no products